Search

everythinglearnresearchcommunity

for

Search:↓

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Heat-killed Enterococcus faecalis EF-2001 may promote hair growth and transition hair follicles to the growth phase.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Applying a special compound can promote hair growth without harmful side effects.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Thymosin β4 helps improve skin healing and reduce scarring.